AB
Insider selling
Anthony Bergmann sold Capricor Therapeutics, Inc. (CAPR) stock
Anthony Bergmann, Chief Financial Officer of Capricor Therapeutics, Inc. (CAPR), sold 24,100 shares of CAPR stock, per an SEC Form 4 filed Jun 30, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Jun 25, 2026, 5 days before it was made public.
CAPR has moved -70.7% since the trade date, from $30.40 to $8.90 (Sep 21, 2026 close).
- Traded
- Jun 25, 2026
- Disclosed
- Jun 30, 2026
- Filing delay
- 5 days
- Price since
- -70.7%
- Role
- Chief Financial Officer
- Source
- SEC Form 4
More CAPR insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.